WASHINGTON, DC—The short-term use of colchicine at the time of TAVI for severe aortic stenosis may curb the risk of new-onset atrial fibrillation (AF) and the need for a new permanent pacemaker, the ...

The benefits of low-dose colchicine (Colcrys) are consistent if started months or years after acute coronary syndrome (ACS) in patients with stable coronary artery disease, a new LoDoCo2 subanalysis ...

Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered randomized trial, researchers found. Between acute MI patients randomized to ...

(UPDATED) Colchicine taken at a daily dose of 0.5 mg safely reduces cardiovascular events among patients with chronic coronary disease, according to data from the placebo-controlled randomized LoDoCo2 ...

An anti-inflammatory drug that has been around for over 2,000 years might help delay a very modern problem: hip and knee replacements. That's the suggestion of a new study finding that older adults ...

The drug colchicine may reduce cardiovascular outcomes among patients with gout, based on a range of retrospective data that suggest improved outcomes and mechanistic connections between gout and ...

Overview: Colchicine tablets, capsules, and liquid are used to reduce complications from coronary artery disease, treat Familial Mediterranean Fever, and treat or prevent gout attacks. The most common ...

Please provide your email address to receive an email when new articles are posted on . Colchicine treatment increases the rate of diarrhea and adverse gastrointestinal events, but not liver, sensory, ...

Colchicine is a generic prescription medication used to prevent gout flares and treat familial Mediterranean fever (FMF) in adults and certain children. Like most drugs, colchicine can cause side ...

Please provide your email address to receive an email when new articles are posted on . In patients with chronic coronary disease, the beneficial effects of colchicine were consistent regardless of ...